Womens presenting with regular menstrual migraine treated with triptans will be included in the study. Self-measure of ICP will be performed outside and during menstrual migraine attacks. The potential variations will be compared to the measures done on matched healthy women outside and during menses.
Age
18–50
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
18 to 50 non menopausal women
Menstrual migraine
Using a triptan as usual treatment to relieve attacks
Usual triptan efficacy although recurrence is possible
